Abstract:Background: Menopause in women marks the knot of reproductive life, and menopause is defined as the last menstrual period in a woman, but this is caused by the failure of the ovarian reserve. The average age of natural menopause in the general population of women has remained around 50–52 years. Premature ovarian insufficiency (POI) is a debilitating clinical syndrome that manifests as a decline in ovarian function in women under 40. This condition is a prominent cause of female infertility. Summary: POI is a debilitating condition that not only wreaks havoc on patients’ physical and mental well-being but also imposes substantial mental, psychological, and economic burdens, particularly on women. In addition to diminished fertility, individuals afflicted with POI face an elevated risk of developing debilitating conditions such as osteoporosis and cardiovascular disease. The etiologies of POI are highly heterogeneous, and it can be caused by spontaneous genetic defects or induced by autoimmune diseases, infections, and iatrogenic or environmental factors. Alarmingly, idiopathic POI, a subtype characterized by an unknown etiology, accounts for more than half of all POI cases. Currently, clinical interventions for POI primarily consist of hormone replacement therapy. Fertility preservation methods are cryopreservation of embryos, oocytes, and ovarian tissue. Immunological interventions, gene editing techniques, and stem cell-based therapies are being explored to unravel the diverse etiologies and underlying mechanisms of POI, thereby enabling the identification of optimal therapeutic interventions. These innovative approaches offer unprecedented opportunities to advance the field of reproductive medicine. Key Messages: The main aim of this paper was to offer a succinct summary of the latest research breakthroughs concerning the elucidation of the mechanisms governing the origin and management of POI.

Oligogenic basis of premature ovarian insufficiency: an observational study

Genetic Screening in Patients with Ovarian Dysfunction

An Update on Primary Ovarian Insufficiency

Landscape of pathogenic mutations in premature ovarian insufficiency

Genetic insights into the complexity of premature ovarian insufficiency

Penetrance of Pathogenic Genetic Variants Associated With Premature Ovarian Insufficiency

Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants

Transcriptomic profile of premature ovarian insufficiency with RNA-sequencing

X chromosome rearrangement associated with premature ovarian insufficiency as diagnosed by molecular cytogenetic methods: a case report and review of the literature

A Preliminary Study on the Mechanism of Premature Ovarian Failure

Searching for the 'X' factor: investigating the genetics of primary ovarian insufficiency

Premature ovarian insufficiency

Epigenetic regulation in premature ovarian failure: A literature review

Primary ovarian insufficiency: update on clinical and genetic findings

Identification of pathogenic DNA variants in premature ovarian insufficiency

Pathogenic variants of meiotic double strand break (DSB) formation genes PRDM9 and ANKRD31 in premature ovarian insufficiency

DNA double-strand break genetic variants in patients with premature ovarian insufficiency

Association of 8q22.3 locus in Chinese Han with idiopathic premature ovarian failure (POF).

Identification and Characterization of Novel Compound Heterozygous Variants in FSHR Causing Primary Ovarian Insufficiency with Resistant Ovary Syndrome.

Basonuclin 1 Deficiency is a Cause of Primary Ovarian Insufficiency.

Research Progress on the Etiology and Treatment of Premature Ovarian Insufficiency